WASHINGTON — It’s on the lips of every presidential candidate, Speaker Nancy Pelosi, and even President Trump: It’s time to lower drug prices. And yet when Congress passed a drug pricing bill last week that will save the government $3 billion — the first it’s passed in nearly a year — no one really noticed.

You can’t blame them: There was no press conference from the bill sponsors, no snarky reaction from the drug industry, virtually no press release from any of the advocacy organizations that champ at the bit to weigh in on every twist and turn of the ongoing drug pricing debate in Washington. Even Trump, who has been eager to show his progress on lowering the costs of drugs, didn’t hold a signing ceremony for the bill.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • SMH !!!! (Shaking my head) for those that don’t know what that mean. You know who’s going to be the
    big winners here? The PBM’s ! There are literally 100’s of articles telling how the PBM’s are ripping off
    every american, the Federal Medicare program and every states Medicaid program, yet there was not
    one mention of the PBM’s and their spread Pricing or the billions they’re making on DIR fees or GER fees. The Congressional Budget Office estimates that the new law will save the government $3.1 billion over 10 years. If these new laws would have included all the money the PBM’s stole that figure would have been $31 billion over 10 years !! PBM’s don’t like change, and they got exactly what they wanted.
    Very sad……… SMH !!!

Your daily dose of news in health and medicine

Privacy Policy